Buniatian, G.H.; Weiskirchen, R.; Weiss, T.S.; Schwinghammer, U.; Fritz, M.; Seferyan, T.; Proksch, B.; Glaser, M.; Lourhmati, A.; Buadze, M.;
et al. Antifibrotic Effects of Amyloid-Beta and Its Loss in Cirrhotic Liver. Cells 2020, 9, 452.
https://doi.org/10.3390/cells9020452
AMA Style
Buniatian GH, Weiskirchen R, Weiss TS, Schwinghammer U, Fritz M, Seferyan T, Proksch B, Glaser M, Lourhmati A, Buadze M,
et al. Antifibrotic Effects of Amyloid-Beta and Its Loss in Cirrhotic Liver. Cells. 2020; 9(2):452.
https://doi.org/10.3390/cells9020452
Chicago/Turabian Style
Buniatian, Gayane Hrachia, Ralf Weiskirchen, Thomas S. Weiss, Ute Schwinghammer, Martin Fritz, Torgom Seferyan, Barbara Proksch, Michael Glaser, Ali Lourhmati, Marine Buadze,
and et al. 2020. "Antifibrotic Effects of Amyloid-Beta and Its Loss in Cirrhotic Liver" Cells 9, no. 2: 452.
https://doi.org/10.3390/cells9020452
APA Style
Buniatian, G. H., Weiskirchen, R., Weiss, T. S., Schwinghammer, U., Fritz, M., Seferyan, T., Proksch, B., Glaser, M., Lourhmati, A., Buadze, M., Borkham-Kamphorst, E., Gaunitz, F., Gleiter, C. H., Lang, T., Schaeffeler, E., Tremmel, R., Cynis, H., Frey, W. H., II, Gebhardt, R.,
... Danielyan, L.
(2020). Antifibrotic Effects of Amyloid-Beta and Its Loss in Cirrhotic Liver. Cells, 9(2), 452.
https://doi.org/10.3390/cells9020452